ProCE Banner Activity

My Thoughts on Current and Future Prophylactic and Therapeutic Strategies for GVHD

Clinical Thought
Review this expert commentary on current and future therapeutic and prophylactic strategies for GVHD.

Released: April 27, 2021

Expiration: April 26, 2022

No longer available for credit.

Share

Faculty

Corey Cutler

Corey Cutler, MD, MPH, FRCPC

Associate Professor of Medicine
Harvard Medical School
Medical Director, Stem Cell Transplantation
Dana-Farber Cancer Institute
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Incyte Corporation

Faculty Disclosure

Primary Author

Corey Cutler, MD, MPH, FRCPC

Associate Professor of Medicine
Harvard Medical School
Medical Director, Stem Cell Transplantation
Dana-Farber Cancer Institute
Boston, Massachusetts

Corey S. Cutler, MD, MPH, FRCPC, has disclosed that he has received consulting fees from CareDx, Fresenius Kabi, Incyte, Janssen, Jazz, Kadmon, and Mesoblast, and other financial or material support from Omeros.